EMEA-001439-PIP01-13-M02

Key facts

Invented name
Exviera
Active substance
Dasabuvir (sodium monohydrate)
Therapeutic area
Infectious diseases
Decision number
P/0174/2018
PIP number
EMEA-001439-PIP01-13-M02
Pharmaceutical form(s)
  • Tablet
  • Age appropriate oral solid form
Condition(s) / indication(s)
Treatment of chronic hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd

E-mail: paediatricteam@abbvie.com
Tel. ++44 7584140100

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating